Details for Patent: 9,108,973
✉ Email this page to a colleague
Which drugs does patent 9,108,973 protect, and when does it expire?
Patent 9,108,973 protects LYTGOBI and is included in one NDA.
This patent has twenty-seven patent family members in twenty-three countries.
Drugs Protected by US Patent 9,108,973
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taiho Oncology | LYTGOBI | futibatinib | TABLET;ORAL | 214801-001 | Sep 30, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | METHOD OF TREATING INTRAHEPATIC CHOLANGIOCARCINOMA | ⤷ Sign Up | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,108,973
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2657233 | ⤷ Sign Up | 301254 | Netherlands | ⤷ Sign Up |
| European Patent Office | 2657233 | ⤷ Sign Up | CA 2023 00036 | Denmark | ⤷ Sign Up |
| European Patent Office | 2657233 | ⤷ Sign Up | CR 2023 00036 | Denmark | ⤷ Sign Up |
| European Patent Office | 2657233 | ⤷ Sign Up | 2023C/548 | Belgium | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
